-77%

est. 2Y upside i

Series A

Automated ERP for distributors.

Rank

#3000

Sector

Enterprise Software, Distribution

Est. Liquidity

~4Y

Data Quality

Data: Low

Recurrency operates in a large, underserved market with a compelling product that integrates with legacy ERPs.

Last updated: March 10, 2026

Bull (10%)+400%

Recurrency successfully captures significant market share by proving its modular, AI-powered layer offers superior ROI and faster integration than incumbent full-suite ERP overhauls. This leads to rapid customer acquisition and expansion, pushing revenue to $100M+ by 2028 and justifying a $600M+ valuation (5x current estimated valuation) at a favorable multiple, potentially leading to an acquisition by a larger tech player seeking to modernize their distribution offerings.

Base (45%)+50%

Recurrency continues to grow steadily within its niche, securing more mid-sized distribution customers and demonstrating the value of its AI automation. However, competitive pressure from incumbents developing similar features limits aggressive market penetration. Revenue reaches $30M-$40M by 2028, leading to a modest valuation increase to $180M-$200M, representing a 50% upside from the current estimated valuation, likely through a Series B or C round.

Bear (45%)-80%

Dominant ERP incumbents like Oracle (NetSuite) and SAP rapidly integrate their own AI-powered automation layers, commoditizing Recurrency's core offering and leveraging their vast sales channels and existing customer relationships. Recurrency struggles to differentiate, growth stalls, and a lack of further funding leads to a down round or distressed acquisition at a valuation of $20M-$30M, wiping out most common stock value given the $25.5M in liquidation preferences.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Investors hold $25.5M in liquidation preferences ahead of common shareholders, representing 21.25% of the estimated current $120M valuation.

Dilution Risk

high

As a Series A company, Recurrency will likely require additional funding rounds (Series B, C, etc.), which will lead to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for Recurrency's private shares at this early stage.

Questions to Ask at the Interview

Strategic questions based on Recurrency's data — designed to show you've done your homework.

  • 1

    “Given the high incumbent threat from major ERP players like SAP and Oracle, how does Recurrency plan to maintain and expand its competitive moat beyond its current modular integration strategy?”

  • 2

    “With a TAM of $4.1B and low market penetration, what are the key strategies for accelerating customer acquisition and expanding beyond the notable customers mentioned, particularly in a capital-efficient manner?”

  • 3

    “Considering the Series A funding in 2023 and the current stage, what is the anticipated timeline for the next funding round or a potential liquidity event for employees, and how is the company managing potential dilution?”

Community

Valuation Sentiment

Our model estimates -77% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.